Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
Metabolites
|
April 28, 2023
Screening for NAFLD-Current Knowledge and Challenges
Roberta Forlano, Giordano Sigon, Benjamin H Mullish, et al.
Journal of Hepatology
|
August 7, 2012
Regression of fibrosis: the need for quantitative methods of assessment
Emmanuel A Tsochatzis, Pinelopi Manousou, Amar P Dhillon, et al.
Diabetes, Obesity & Metabolism
|
February 18, 2026
Associations between use of aspirin and magnetic resonance imaging-derived liver fat and fibroinflammation
Qi Feng, Pinelopi Manousou, Chioma N Izzi-Engbeaya, et al.
Molecular and Cellular Biochemistry
|
July 17, 2008
Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells
George Kolios, Vassilis Valatas, Pinelopi Manousou, et al.
Biological Imaging
|
March 21, 2024
Fibrosis severity scoring on Sirius red histology with multiple-instance deep learning
Sneha N Naik, Roberta Forlano, Pinelopi Manousou, et al.
Gut
|
December 17, 2010
Validating non-invasive markers of fibrosis: the need for a new histological reference standard
Emmanuel A Tsochatzis, Pinelopi Manousou, Giuseppe Fede, et al.
International Journal of Molecular Sciences
|
January 21, 2022
The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
Roberta Forlano, Benjamin H Mullish, Lauren A Roberts, et al.
Alimentary Pharmacology & Therapeutics
|
March 29, 2019
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply
Benjamin H Mullish, Roberta Forlano, Robin Daniel Abeles, et al.
Alimentary Pharmacology & Therapeutics
|
October 29, 2019
Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply
Benjamin H Mullish, Roberta Forlano, R Daniel Abeles, et al.
World Journal of Gastroenterology
|
March 6, 2019
Current and future pharmacological therapies for managing cirrhosis and its complications
David Kockerling, Rooshi Nathwani, Roberta Forlano, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
Metabolites
|
April 28, 2023
Screening for NAFLD-Current Knowledge and Challenges
Roberta Forlano, Giordano Sigon, Benjamin H Mullish, et al.
Journal of Hepatology
|
August 7, 2012
Regression of fibrosis: the need for quantitative methods of assessment
Emmanuel A Tsochatzis, Pinelopi Manousou, Amar P Dhillon, et al.
Diabetes, Obesity & Metabolism
|
February 18, 2026
Associations between use of aspirin and magnetic resonance imaging-derived liver fat and fibroinflammation
Qi Feng, Pinelopi Manousou, Chioma N Izzi-Engbeaya, et al.
Molecular and Cellular Biochemistry
|
July 17, 2008
Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells
George Kolios, Vassilis Valatas, Pinelopi Manousou, et al.
Biological Imaging
|
March 21, 2024
Fibrosis severity scoring on Sirius red histology with multiple-instance deep learning
Sneha N Naik, Roberta Forlano, Pinelopi Manousou, et al.
Gut
|
December 17, 2010
Validating non-invasive markers of fibrosis: the need for a new histological reference standard
Emmanuel A Tsochatzis, Pinelopi Manousou, Giuseppe Fede, et al.
International Journal of Molecular Sciences
|
January 21, 2022
The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
Roberta Forlano, Benjamin H Mullish, Lauren A Roberts, et al.
Alimentary Pharmacology & Therapeutics
|
March 29, 2019
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply
Benjamin H Mullish, Roberta Forlano, Robin Daniel Abeles, et al.
Alimentary Pharmacology & Therapeutics
|
October 29, 2019
Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply
Benjamin H Mullish, Roberta Forlano, R Daniel Abeles, et al.
World Journal of Gastroenterology
|
March 6, 2019
Current and future pharmacological therapies for managing cirrhosis and its complications
David Kockerling, Rooshi Nathwani, Roberta Forlano, et al.
Page
of 9